Martin G K, Jassir D, Stagner B B, Lonsbury-Martin B L
Department of Otolaryngology, University of Miami School of Medicine, Florida 33101-6960, USA.
J Acoust Soc Am. 1998 Aug;104(2 Pt 1):972-83. doi: 10.1121/1.423340.
The suppression tuning of distortion-product otoacoustic emissions (DPOAEs) is commonly assumed to measure frequency selectivity, because the dominant features of suppression-tuning curves (STCs) are similar to the principal properties of the neural-tuning curves (NTCs) of single auditory-nerve fibers. In the present study, several common loop diuretics were used to affect the DPOAE-generation process to determine if reversible ototoxicity could adversely modify the characteristics of STCs, in a manner similar to that shown previously for NTCs. Contour plots of DPOAE level in the presence of a series of variable-level suppressor tones were obtained before and after administering diuretic drugs that reversibly reduced or eliminated DPOAEs. Primary-tone pairs were centered at 2.8 or 4 kHz, with L1 = L2, or L2 < L1. From the resulting plots, STC parameters including tip frequency, threshold at the tip frequency, and Q10 dB measures of tuning were extracted for four suppression criteria of 3, 6, 9, and 12 dB. In the pre-drug nonototoxic state, suppression tuning depended on both primary-tone level (L1, L2), and the relative levels of the primaries (L1-L2), with tuning being sharper for lower- than for higher-level equilevel primaries, and sharpest for offset-level primary tones. Following drug injection, the expected decrease in sharpness of tuning evidenced by changes in Q10 dB as well as the dramatically elevated tip thresholds normally seen for NTCs under similar conditions, were not observed. Overall, Q10 dB increased or decreased more or less randomly, with a slight tendency for STCs to become sharper than prior to drug dosing, for the two highest suppression criteria. The STC-tip frequencies demonstrated significant decreases following diuretic administration that were weakly correlated with the associated decreases in DPOAE amplitude. The most consistent changes in response to the drug-induced reduction in DPOAE level were increases in the STC-tip thresholds. However, these changes were relatively small and rarely exceeded 10 dB. In the absence of notable changes in overall STC shape, a major finding was a change in the effectiveness of suppression following ototoxic insult. However, when the amount of suppression was expressed as a percentage of the DPOAE remaining, the effects of diuretic dosing were often almost completely obscured. Overall, the results demonstrated that when the generation of DPOAEs was interfered with by the introduction of a suppressor tone to produce STCs that resemble NTCs, STCs behaved quite differently following reversible cochlear insult than their previously documented neural counterparts. These findings imply that STCs do not assess the frequency-selective aspects of the cochlear amplification process in a manner similar to NTCs.
畸变产物耳声发射(DPOAE)的抑制调谐通常被认为可用于测量频率选择性,因为抑制调谐曲线(STC)的主要特征与单个听神经纤维的神经调谐曲线(NTC)的主要特性相似。在本研究中,使用了几种常见的袢利尿剂来影响DPOAE的产生过程,以确定可逆性耳毒性是否会以类似于先前在NTC中所显示的方式对STC的特征产生不利影响。在给予可逆性降低或消除DPOAE的利尿药物之前和之后,获得了一系列可变水平抑制音存在时DPOAE水平的等高线图。初级音对的中心频率为2.8或4 kHz,L1 = L2,或L2 < L1。从所得图中,针对3、6、9和12 dB的四个抑制标准提取了STC参数,包括尖峰频率、尖峰频率处的阈值以及10 dB调谐Q值测量。在用药前的非耳毒性状态下,抑制调谐取决于初级音水平(L1、L2)以及初级音的相对水平(L1 - L2),对于较低水平而非较高水平的等水平初级音,调谐更尖锐,对于偏移水平的初级音则最尖锐。注射药物后,未观察到如通过10 dB Q值变化所证明的调谐锐度预期下降以及在类似条件下NTC通常所见的尖峰阈值显著升高。总体而言,10 dB Q值或多或少随机增加或减少,对于两个最高抑制标准,STC有比给药前变得更尖锐的轻微趋势。利尿剂给药后,STC尖峰频率显著下降,与DPOAE幅度的相关下降弱相关。对药物诱导的DPOAE水平降低最一致的反应变化是STC尖峰阈值升高。然而,这些变化相对较小,很少超过10 dB。在整体STC形状无明显变化的情况下,一个主要发现是耳毒性损伤后抑制效果的变化。然而,当抑制量表示为剩余DPOAE的百分比时,利尿剂给药的影响往往几乎完全被掩盖。总体而言,结果表明,当通过引入抑制音干扰DPOAE的产生以产生类似于NTC的STC时,可逆性耳蜗损伤后STC的表现与其先前记录的神经对应物有很大不同。这些发现意味着STC不能以类似于NTC的方式评估耳蜗放大过程的频率选择性方面。